SNRNP70
U1 small nuclear ribonucleoprotein 70 kDa
Also known as: RNPU1Z, RPU1, RU17_HUMAN, Snp1, SNRP70, U1-70K
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P08621
- Gene
- SNRNP70
- Ensembl
- ENSG00000104852
- Chromosome
- 19
- Canonical length
- 437 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Enables U1 snRNA binding activity. Involved in mRNA splicing, via spliceosome and regulation of RNA splicing. Located in nucleoplasm. Part of U1 snRNP and spliceosomal complex. Implicated in disease of mental health and systemic lupus erythematosus. Biomarker of Alzheimer's disease. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
437 residues, UniProt reviewed canonical sequence.
>P08621|SNRNP70
1 MTQFLPPNLL ALFAPRDPIP YLPPLEKLPH EKHHNQPYCG IAPYIREFED PRDAPPPTRA
61 ETREERMERK RREKIERRQQ EVETELKMWD PHNDPNAQGD AFKTLFVARV NYDTTESKLR
121 REFEVYGPIK RIHMVYSKRS GKPRGYAFIE YEHERDMHSA YKHADGKKID GRRVLVDVER
181 GRTVKGWRPR RLGGGLGGTR RGGADVNIRH SGRDDTSRYD ERPGPSPLPH RDRDRDRERE
241 RRERSRERDK ERERRRSRSR DRRRRSRSRD KEERRRSRER SKDKDRDRKR RSSRSRERAR
301 RERERKEELR GGGGDMAEPS EAGDAPPDDG PPGELGPDGP DGPEEKGRDR DRERRRSHRS
361 ERERRRDRDR DRDRDREHKR GERGSERGRD EARGGGGGQD NGLEGLGNDS RDMYMESEGG
421 DGYLAPENGY LMEAAPELocalizationUniProt · AlphaFold · HPA
Whether an antibody against SNRNP70 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.54
- Highest tissue expression
- 136 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 136 nTPM
- adrenal gland: 112 nTPM
- spleen: 107 nTPM
- esophagus: 107 nTPM
- liver: 106 nTPM
- pituitary gland: 105 nTPM
Single-cell type
- extravillous trophoblasts: 261 nCPM
- migrating cytotrophoblasts: 249 nCPM
- astrocytes: 237 nCPM
- esophageal basal cells: 234 nCPM
- sertoli cells: 233 nCPM
- proximal tubule cells: 223 nCPM
Immune cell
- NK-cell: 4.1 nTPM
- memory B-cell: 4 nTPM
- classical monocyte: 2 nTPM
- myeloid DC: 2 nTPM
- naive CD4 T-cell: 2 nTPM
- eosinophil: 1.8 nTPM
Brain region
- cerebral cortex: 44 nTPM
- white matter: 42 nTPM
- hypothalamus: 39 nTPM
- choroid plexus: 34 nTPM
- amygdala: 34 nTPM
- cerebellum: 33 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SNRNP70.
Disease | ImmuneIEDB
Conditions an epitope on SNRNP70 was assayed in.
- systemic lupus erythematosus B and T cell
- mixed connective tissue disease B and T cell
- rheumatoid arthritis T cell
- viral infectious disease T cell
Disease | AutoantibodyPubMed
Conditions in which antibodies against SNRNP70 are reported. Each links to that disease's full target list.
- Lupus Erythematosus, Systemic 81
- Scleroderma, Systemic 51
- Mixed Connective Tissue Disease 47
- Lupus Erythematosus, Cutaneous 12
- Hypertension, Pulmonary 11
- Sjogren's Syndrome 11
- Raynaud Disease 9
- Heart Block 8
- Myositis 8
- Dermatomyositis 7
- Collagen Diseases 5
- Lung Diseases, Interstitial 5
- Lupus Nephritis 5
- Lupus Vasculitis, Central Nervous System 5
- Arthritis, Rheumatoid 4
- Polymyositis 4
- Arthritis 3
- Pulmonary Fibrosis 3
- Scleroderma, Localized 3
Showing 19 of 21 — disease pages carrying at least 10 antigens.
ReferencesPubMed · IEDB
Publications for SNRNP70 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
223 publications
- The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome.
2014 · Autoimmun Rev · RCR 9.2 · 227 citations - Anti-U1RNP antibodies are associated with a distinct clinical phenotype and a worse survival in patients with systemic sclerosis.
2024 · J Autoimmun · RCR 4.8 · 19 citations - Autoantibodies as predictive tools in systemic sclerosis.
2010 · Nat Rev Rheumatol · RCR 4.4 · 148 citations - Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
2010 · J Dermatol · RCR 4.4 · 146 citations - Anti-muscarinic 3 antibodies associate with a severe clinical phenotype in patients with systemic sclerosis.
2025 · Rheumatology (Oxford) · RCR 4.3 · 10 citations
Show 20 more of 223 total
- Neonatal lupus erythematosus.
1993 · J Invest Dermatol · RCR 4.2 · 95 citations - Clinical characteristics and survival of pulmonary arterial hypertension associated with three major connective tissue diseases: A cohort study in China.
2017 · Int J Cardiol · RCR 3.9 · 80 citations - Systemic sclerosis and lupus: points in an interferon-mediated continuum.
2010 · Arthritis Rheum · RCR 3.8 · 154 citations - The diagnosis and classification of mixed connective tissue disease.
2014 · J Autoimmun · RCR 3.8 · 92 citations - Clinical, serologic, and immunogenetic studies in childhood-onset systemic lupus erythematosus.
1993 · Arthritis Rheum · RCR 3.7 · 109 citations - Childhood onset systemic sclerosis: classification, clinical and serologic features, and survival in comparison with adult onset disease.
2006 · J Rheumatol · RCR 3.6 · 111 citations - Characteristics and Survival of Anti-U1 RNP Antibody-Positive Patients With Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.
2016 · Arthritis Rheumatol · RCR 3.3 · 74 citations - Clinical features and serum antinuclear antibodies in 230 Danish patients with systemic sclerosis.
1998 · Br J Rheumatol · RCR 3.3 · 89 citations - Prevalence of disease-specific antinuclear antibodies in general population: estimates from annual physical examinations of residents of a small town over a 5-year period.
2008 · Mod Rheumatol · RCR 3.2 · 107 citations - Importance of the immune response to the Ro/La particle in the development of congenital heart block and neonatal lupus erythematosus.
1991 · J Rheumatol · RCR 3.2 · 80 citations - Narrative review of autoantibodies in idiopathic inflammatory myopathies.
2023 · Ann Transl Med · RCR 3.1 · 17 citations - Comparative study of 4 diagnosis criteria sets for mixed connective tissue disease in patients with anti-RNP antibodies. Autoimmunity Group of the Hospitals of Toulouse.
1996 · J Rheumatol · RCR 3 · 86 citations - Pulmonary arterial hypertension in systemic lupus erythematosus: current status and future direction.
2012 · Clin Dev Immunol · RCR 2.9 · 79 citations - Calcinosis is associated with digital ulcers and osteoporosis in patients with systemic sclerosis: A Scleroderma Clinical Trials Consortium study.
2016 · Semin Arthritis Rheum · RCR 2.9 · 57 citations - South Australian Scleroderma Register: autoantibodies as predictive biomarkers of phenotype and outcome.
2012 · Int J Rheum Dis · RCR 2.8 · 82 citations - The clinical relevance of serum antinuclear antibodies in Japanese patients with systemic sclerosis.
2008 · Br J Dermatol · RCR 2.8 · 94 citations - Racial differences in the frequencies of scleroderma-related autoantibodies.
1992 · Arthritis Rheum · RCR 2.6 · 68 citations - Muscular and extramuscular features of myositis patients with anti-U1-RNP autoantibodies.
2019 · Neurology · RCR 2.5 · 37 citations - Correlation of interferon-inducible chemokine plasma levels with disease severity in systemic sclerosis.
2013 · Arthritis Rheum · RCR 2.5 · 85 citations - Interstitial lung disease in anti-U1RNP systemic sclerosis patients: A European Scleroderma Trials and Research analysis.
2025 · J Scleroderma Relat Disord · RCR 2.5 · 6 citations
Reference: B cellIEDB
10 publications
- T cell recognition and therapeutic effect of a phosphorylated synthetic peptide of the 70K snRNP protein administered in MR/lpr mice.
2003 · Eur J Immunol · RCR 2.2 · 113 citations - Human anti-p68 autoantibodies recognize a common epitope of U1 RNA containing small nuclear ribonucleoprotein and influenza B virus.
1990 · J Exp Med · RCR 1.7 · 63 citations - Human lupus anti-spliceosome A protein autoantibodies bind contiguous surface structures and segregate into two sequential epitope binding patterns.
1996 · J Immunol · RCR 0.8 · 33 citations - Major autoantigenic sites of the (U1) small nuclear ribonucleoprotein-specific 68-kDa protein.
1990 · Scand J Immunol · RCR 0.7 · 34 citations - Early targets of nuclear RNP humoral autoimmunity in human systemic lupus erythematosus.
2009 · Arthritis Rheum · RCR 0.7 · 30 citations
Show 5 more
- Basic amino acids predominate in the sequential autoantigenic determinants of the small nuclear 70K ribonucleoprotein.
1994 · Scand J Immunol · RCR 0.7 · 27 citations - Repetitive P68-autoantigen specific epitopes recognized by human anti-(U1) small nuclear ribonucleoprotein autoantibodies.
1991 · J Autoimmun · RCR 0.6 · 20 citations - Detection of epitopes in systemic lupus erythematosus using peptide microarray.
2018 · Mol Med Rep · RCR 0.4 · 7 citations - Autoepitope-mapping of the U1-70K protein with human-Drosophila chimeric proteins.
1997 · J Autoimmun · RCR 0.3 · 12 citations - Epitope mapping of the U1 small nuclear ribonucleoprotein particle in patients with systemic lupus erythematosus and mixed connective tissue disease.
2011 · Lupus · RCR 0.2 · 9 citations
Reference: T cellIEDB
4 publications
- EBV-gp350 confers B-cell tropism to tailored exosomes and is a neo-antigen in normal and malignant B cells--a new option for the treatment of B-CLL.
2011 · PLoS One · RCR 1.5 · 60 citations - Selective modulation of CD4+ T cells from lupus patients by a promiscuous, protective peptide analog.
2005 · J Immunol · RCR 0.9 · 47 citations - T cell immunity in connective tissue disease patients targets the RNA binding domain of the U1-70kDa small nuclear ribonucleoprotein.
2002 · J Immunol · RCR 0.6 · 32 citations - CD4+ T cells target epitopes residing within the RNA-binding domain of the U1-70-kDa small nuclear ribonucleoprotein autoantigen and have restricted TCR diversity in an HLA-DR4-transgenic murine model of mixed connective tissue disease.
2008 · J Immunol · RCR 0.2 · 12 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.19
- gnomAD pLI
- 1
- gnomAD missense Z
- 3.45
- DepMap mean gene effect
- -1.1
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to retinoic acid
- cellular response to transforming growth factor beta stimulus
- cellular response to tumor necrosis factor
- mRNA splicing, via spliceosome
- negative regulation of chaperone-mediated autophagy
- negative regulation of protein refolding
- positive regulation of mRNA splicing, via spliceosome
- regulation of RNA splicing
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- RNA recognition motif domain
- Nucleotide-binding alpha-beta plait domain superfamily
- RNA-binding domain superfamily
- U1 snRNP 70 kDa and U11/U12 snRNP 35 kDa
- RNA recognition motif
- U1 small nuclear ribonucleoprotein of 70kDa N-terminal
- snRNP70, RNA recognition motif
- U1 small nuclear ribonucleoprotein of 70kDa MW N terminal
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SNRNP70 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SNRNP70 as an antibody target. Whether an autoantibody or antibody against SNRNP70 could matter depends on whether native SNRNP70 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SNRNP70 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SNRNP70 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...